David A. Siegel Molecular Templates, Inc. Transaction History

Two Sigma Advisers, LP

  • $41.3 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$0.33 - $12.0 $23,001 - $836,400
-69,700 Reduced 27.71%
181,829 $60,000
Q3 2022

Nov 14, 2022
SELL
$0.68 - $11.25 $70,176 - $1.16 Million
-103,200 Reduced 29.09%
251,529 $189,000
Q2 2022

Aug 15, 2022
BUY
$0.81 - $3.43 $83,511 - $353,633
103,100 Added 40.97%
354,729 $323,000
Q1 2022

May 16, 2022
SELL
$2.27 - $4.13 $216,558 - $394,002
-95,400 Reduced 27.49%
251,629 $868,000
Q4 2021

Feb 14, 2022
SELL
$3.37 - $6.87 $117,950 - $240,450
-35,000 Reduced 9.16%
347,029 $1.36 Million
Q3 2021

Nov 15, 2021
BUY
$5.78 - $7.86 $358,360 - $487,320
62,000 Added 19.37%
382,029 $2.56 Million
Q2 2021

Aug 16, 2021
BUY
$7.82 - $12.44 $12,512 - $19,904
1,600 Added 0.5%
320,029 $2.5 Million
Q1 2021

May 17, 2021
SELL
$9.33 - $14.05 $491,691 - $740,435
-52,700 Reduced 14.2%
318,429 $4.02 Million
Q4 2020

Feb 16, 2021
BUY
$8.48 - $12.23 $883,616 - $1.27 Million
104,200 Added 39.04%
371,129 $3.49 Million
Q3 2020

Nov 16, 2020
BUY
$9.99 - $14.41 $1.62 Million - $2.34 Million
162,600 Added 155.85%
266,929 $2.92 Million
Q2 2020

Aug 14, 2020
BUY
$12.28 - $17.63 $763,816 - $1.1 Million
62,200 Added 147.64%
104,329 $1.44 Million
Q1 2020

May 15, 2020
BUY
$11.31 - $18.26 $476,478 - $769,275
42,129 New
42,129 $560,000

Others Institutions Holding MTEM

# of Institutions
2
Shares Held
499K
Call Options Held
0
Put Options Held
0
View Full List

About Molecular Templates, Inc.

MTEM Quotes by TradingView
  • Ticker MTEM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,351,600
  • Description
  • Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...
More about MTEM
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email